“If you or a loved one has been diagnosed with cancer in the past two years and regularly took Zantac for the last 4 years, call us. You may have a case.” Eric Artrip
Sandoz Inc. has issued a voluntary recall after confirming that the generic Zantac capsules contained an “unexpected impurity, N-Nitrosodimethylamine (NDMA), which is like a human carcinogen.
The FDA issued an advisory on September 13, 2019, warning the public of a Zantac Cancer risk due to chemical contamination of the heartburn medication.
The U.S. Food and Drug Administration has learned that some ranitidine medicines, including some products commonly known as the brand-name drug Zantac, contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests.
